Fundraising Fox

ACX

YC S24

New York City, US · Founded 2024 · 4 employees · 1 known investors

ACX develops bioengineered solutions for pest control in agriculture, replacing synthetic chemicals with precision biocides. The company serves crop producers and aims to enhance food security while reducing chemical dependence and promoting biodiversity.

Also known as AcX Therapeutics

Founders & leadership· Y Combinator alumni (S24)

ACX was founded in 2024 by Emmanouela Petsolari and Melina Petsolari.

EPEmmanouela Petsolari
Emmanouela PetsolariinCo-Founder and CEOEmmanouela Petsolari holds a PhD in Biochemistry and Biophysics from the University of Cambridge and has conducted research across immunology, cancer, vaccine development, and drug discovery at institutions including Barts Cancer Institute, Cambridge University, King's College London, Institute Curie, and Imperial College London. She is Co-Founder and CEO of ACX.
MPMelina Petsolari
Melina PetsolariinCo-Founder and CTOMelina Petsolari holds a PhD in Computer Science from King's College London and previously conducted research in digital health, robotics, human-computer interaction, and natural language processing at institutions including Cambridge University, King's College London, the NHS, and the Francis Crick Institute.

Investors · 1

Competitors · 4

by search overlap

Companies competing with ACX for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does ACX do?
ACX develops bioengineered solutions for pest control in agriculture, replacing synthetic chemicals with precision biocides. The company serves crop producers and aims to enhance food security while reducing chemical dependence and promoting biodiversity.
Who founded ACX?
ACX was founded by Emmanouela Petsolari, Melina Petsolari in 2024.
Who are ACX's investors?
ACX's investors include Y Combinator.
Where is ACX headquartered?
ACX is headquartered in New York City, US.